patients x1AT clearance was compared with faecal 51Cr clearance after intravenous 51Cr-albumin injection. There was a linear relation (p<0O05) between X1AT clearance and 51Cr clearance in these cases. In all patients ox1AT clearance was raised above control values. &1AT clearance, however, did not correlate with the activity index of Crohn's disease.1 This index does not contain direct critieria of intestinal inflammation, does not take into account localisation or extent of inflammation, and includes complications such as extraintestinal manifestations, fistuli, stenoses not necessarily related to actual mucosal involvement. It is concluded that x1AT is a reliable marker for intestinal protein loss and that the intestinal changes of Crohn's disease generally lead to an increased protein exudation into the gut.
Gastrointestinal loss of plasma proteins can be detected by a variety of labelled macromolecules: 59Fe-labelled dextran and 131I_PVP3 are not split by digestive enzymes; the radioactive isotopes 51Cr-albumin,4 67Cu-ceruloplasmins or 95Nb-albumin6 are poorly absorbed by the alimentary tract. These methods are expensive and the patients are exposed to radioactivity and therefore cannot be used routinely as screening-tests or to monitor the course of illness. Crossley and Elliot7 showed that acAT, a protease inhibitor synthesized by the liver and present in serum at a concentration of 2-5 g/l, is not degraded by digestive enzymes nor reabsorbed by the intestine. It has been shown to be a reliable endogenous marker of intestinal protein loss by Bernier and In all patients the CDAI' was established. In the (Fig. 1) . The different methods of treating the faeces with normal saline or aqua dest, the duration of homogenisation, and the rpm of centrifugation, had no influence on the results. After storage of the stool and the serum at -20°C for eight months the recovery rate of o1AT was more than 90%.
In our experiments the faecal loss of alAT in (Fig. 1) should be unity provided both proteins follow the same mechanism of transmucosal exudation, whereas a value of 073 was calculated from our results. There is some destruction of cY,AT in gastric juice of pH below 3,13 but from the results of Crossley and Elliot7 it is unlikely that otAT is degraded in the small or large bowel to any significant degree nor is 51Cr absorbed to any appreciable extent. 14 Moreover, the molecular weights of oxlAT'5 and albumin are comparable and no significant difference exists in exudative enteropathy in the loss of small or large proteins. Hofer et al16 found that chrominated albumin is present in a monomer fraction and in an aggragated 5 Cralbumin fraction. The metabolic behaviour of the aggregate and monomer fraction is different. The aggregate fraction is stored in the liver in a greater amount than the monomer fraction followed by a smaller intestinal exudation, which could possibly explain the difference between ot,AT and 51Cr clearance.
Differences in preparing stool such as dilution, homogenisation, or centrifugation, had no influence on the determination of al AT. Therefore the contradictory results of Bernier et at8 and Haeney et at9 cannot be explained in that way.
Our results confirm those of Bernier et at8 in that no overlap of xlAT clearance was seen in patients and controls, and all patients had raised x1,AT clearance levels (Fig. 2) Accordingly, in patients with complications the mean CDAI was higher than in patients without complications (Fig. 5) . In contrast the mean ox1AT clearance in patients without complications was raised above the values of patients with complications (Fig. 6 ). From this comparison it is obvious that in patients suffering from complications the CDAI reflects a much higher clinical activity as it is evident from the intestinal protein loss indicating severity of the local intestinal inflammation. '4 Discrepancies between the quantity of intestinal protein loss and the activity of Crohn's disease estimated by the Best index may be explained by the absence of mucosal parameters as determining factors for this index. The same reason may apply for the six of 14 patients of Florent et al'3 who had raised x,AT clearances in spite of a normal Best index and developed a relapse on follow up.
Selection of patients may be another cause explaining differences of the studies. Twenty-eight out of the 30 patients of Florent et al '3 with Crohn's disease had marked hypoalbuminemia (mean serum albumin concentration 2.73±0 53 g%). Only nine out of 26 of our patients had albumin concentrations below 3.6 g% (mean value 3 80±057 g%).'7 2(0 Furthermore, these authors studied patients without previous intestinal surgery whereas 10 of our patients had undergone intestinal resection and complications were not documented.
Protein loss via the intestinal wall seems to be one of the most accurate parameters to measure the inflammatory activity in the intestine. 14 
